Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · BIOVIE INC. (BIVI)

BioVie Inc. stockholders approve equity plan increase to 3,100,000 shares

Neutral Impact 2 of 5 shareholder Written later

At its November 10, 2025 annual meeting, BioVie's stockholders approved an amended and restated 2019 Omnibus Equity Incentive Plan, effective that day. The amendment raises the number of common shares authorized for issuance under the plan to 3,100,000, allowing the company to keep granting equity compensation to employees, directors and consultants.

Key points

  • Stockholders approved the amended and restated 2019 Omnibus Equity Incentive Plan on November 10, 2025, effective the same day.
  • Authorized shares under the plan increased to 3,100,000 common shares.
  • Full plan terms are in Appendix A to the Definitive Proxy Statement on Schedule 14A filed September 25, 2025.

The filing

CompanyBIOVIE INC. (BIVI)
Form8-K, current report
Filed with the SECNov 13, 2025, 5:01 PM ET
Accession number0001520138-25-000352

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 13, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.